Curis, Inc. (CRIS) reported net income for the fourth quarter of $6.1 million or $0.07 per share, compared to a net loss of $5.6 million or $0.07 per share for the year-ago quarter.
Revenues for the fourth quarter surged ti $14.1 million from $100,000 a year ago. The increase is the result of $14.0 million in license fee revenues recorded during the fourth quarter of 2011 for payments that Curis received from Genentech for the achievement of certain regulatory objectives related to Erivedge.
Analysts polled by Thomson Reuters expected the company to earn $0.06 per share on revenue of $10.16 million for the fourth quarter.
For comments and feedback: editorial@rttnews.com